Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90


Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent.

Kalkman DN, Woudstra P, Menown IBA, Tijssen JG, Beijk MAM, de Winter RJ; REMEDEE Registry collaborators.

Cardiovasc Revasc Med. 2017 Oct 17. pii: S1553-8389(17)30392-5. doi: 10.1016/j.carrev.2017.10.005. [Epub ahead of print] Review.


Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.

Connolly M, Kinnin M, McEneaney D, Menown I, Kurth M, Lamont J, Morgan N, Harbinson M.

QJM. 2018 Feb 1;111(2):103-110. doi: 10.1093/qjmed/hcx201.


Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI).

Connolly M, Shand J, Kinnin M, Menown I, Kurth MJ, Lamont J, Mc Eneaney D.

QJM. 2018 Jan 1;111(1):33-38. doi: 10.1093/qjmed/hcx193.


Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy.

Carrié D, Menown I, Oldroyd K, Copt S, Talwar S, Maillard L, Morice MC, Teik LS, Lang I, Urban P.

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1633-1642. doi: 10.1016/j.jcin.2017.05.033.


Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry.

Kalkman DN, Woudstra P, Menown IBA, den Heijer P, Van't Hof AW, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, Muller P, Tijssen JG, Beijk MAM, de Winter RJ.

Open Heart. 2017 Jul 11;4(2):e000634. doi: 10.1136/openhrt-2017-000634. eCollection 2017.


Advances in Clinical Cardiology 2016: A Summary of the Key Clinical Trials.

Gray A, McQuillan C, Menown IBA.

Adv Ther. 2017 Jul;34(7):1503-1527. doi: 10.1007/s12325-017-0560-5. Epub 2017 May 23. Review.


Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.

Kalkman DN, Woudstra P, Lu H, Menown IBA, den Heijer P, Suryapranata H, Iñiguez A, Arkenbout KE, Van't Hof AWJ, Muller P, Erglis A, Tijssen JG, Beijk MAM, de Winter RJ.

Catheter Cardiovasc Interv. 2017 Aug 1;90(2):E31-E37. doi: 10.1002/ccd.26915. Epub 2017 Feb 1.


Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE study investigators.

Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31. Erratum in: Lancet. 2016 Dec 3;388(10061):2742.


2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.

Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P; LEADERS FREE Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):162-171. doi: 10.1016/j.jacc.2016.10.009. Epub 2016 Oct 30.


One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.

Kalkman DN, Woudstra P, den Heijer P, Menown IB, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, van 't Hof AW, Muller P, Tijssen JG, de Winter RJ.

Int J Cardiol. 2017 Jan 1;226:60-64. doi: 10.1016/j.ijcard.2016.10.032. Epub 2016 Oct 17.


A Review of the Key Clinical Trials of 2015: Results and Implications.

McCune C, McKavanagh P, Menown IB.

Cardiol Ther. 2016 Dec;5(2):109-132. Epub 2016 Jun 8. Review.


1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.

Woudstra P, Kalkman DN, den Heijer P, Menown IB, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, van 't Hof AW, Muller P, Tijssen JG, de Winter RJ.

JACC Cardiovasc Interv. 2016 Jun 13;9(11):1127-34. doi: 10.1016/j.jcin.2016.02.052. Epub 2016 May 18.


Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.

Zhao M, Cooney MT, Klipstein-Grobusch K, Vaartjes I, De Bacquer D, De Sutter J, Reiner Ž, Prescott E, Faggiano P, Vanuzzo D, AlFaleh H, Menown IB, Gait D, Posogova N, Sheu WH, Zhao D, Zuo H, Grobbee DE, Graham IM.

Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. doi: 10.1177/2047487316647827. Epub 2016 Apr 26.


Resource Utilisation And Bleeding Events During Anticoagulation Treatment: Real-World Findings From England.

Lister S, Lefevre C, Menown I, Alikhan R, Lacoin L, Bird A, You M, Ridha E, Evans D.

Value Health. 2015 Nov;18(7):A396-7. doi: 10.1016/j.jval.2015.09.899. Epub 2015 Oct 20. No abstract available.


Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators.

N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14.


A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients.

McCune C, McKavanagh P, Menown IB.

Cardiol Ther. 2015 Dec;4(2):95-116. doi: 10.1007/s40119-015-0047-x. Epub 2015 Sep 22.


Anomalous Left Main Coronary Artery: Not Always a Simple Surgical Reimplantation.

Khan AH, Menown IB, Graham A, Purvis JA.

Cardiol Ther. 2015 Jun;4(1):77-82. doi: 10.1007/s40119-015-0039-x. Epub 2015 May 5.


A Review of the Key Clinical Trials of 2014.

McKavanagh P, McCune C, Menown IB.

Cardiol Ther. 2015 Jun;4(1):5-23. doi: 10.1007/s40119-015-0036-0. Epub 2015 Mar 27.


Editors' Picks for 2014 and a Look into the Future.

Giugliano RP, Zeymer U, Menown I.

Cardiol Ther. 2015 Jun;4(1):1-3. doi: 10.1007/s40119-015-0038-y. Epub 2015 Mar 13. No abstract available.


Novel Biomarkers of Acute Kidney Injury After Contrast Coronary Angiography.

Connolly M, McEneaney D, Menown I, Morgan N, Harbinson M.

Cardiol Rev. 2015 Sep-Oct;23(5):240-6. doi: 10.1097/CRD.0000000000000058. Review.


Supplemental Content

Loading ...
Support Center